GET DAILY SIGNALSNVAX Witnesses strong performance Surge with AI Trading Robot
Swing Trader: Medium Volatility Stocks for Active Trading (TA&FA) has been on a roll lately, with its AI trading robot generating a strong performance in just 2 trades while trading NVAX over the previous week. This is an impressive performance and highlights the potential benefits of incorporating AI and algorithmic trading strategies into your investment portfolio.
Looking at the Moving Average Convergence Divergence (MACD) indicator for NVAX, we can see that it turned positive on May 09, 2023. This is a bullish signal and suggests that there could be further upside potential for the stock in the near term. In fact, historical data shows that in 43 out of 44 instances where NVAX's MACD turned positive, the stock continued to rise over the following month. This gives the current upward trend a 90% chance of continuation, providing an excellent opportunity for investors to capitalize on the bullish momentum.
However, it's important to consider other fundamental factors that could impact the stock's performance. The last earnings report on May 09 showed earnings per share of -341 cents, beating the estimate of -342 cents. While this is a positive sign, it's worth noting that NVAX's earnings have been volatile in recent years, with significant fluctuations from one quarter to the next.
NVAX currently has 2.60M shares outstanding, with a market capitalization of 641.99M. This puts the stock in the small to mid-cap range, which can offer greater potential for growth but also comes with higher levels of risk. Investors should carefully evaluate their risk tolerance and investment objectives before considering adding NVAX to their portfolio.
In conclusion, Swing Trader's AI trading robot has delivered impressive results with its recent trades on NVAX, and the bullish MACD signal suggests there could be further upside potential in the near term. However, investors should be mindful of the stock's volatile earnings history and small to mid-cap status before making any investment decisions. As always, it's important to conduct thorough research and consult with a financial advisor before making any investment decisions.
Contributor
Momentum Indicator for NVAX turns negative, indicating new downward trend
NVAX saw its Momentum Indicator move below the 0 level on October 21, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In 77 of the 83 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for NVAX moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In 20 of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at 87%.
The Moving Average Convergence Divergence Histogram (MACD) for NVAX turned negative on October 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 38 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
NVAX moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for NVAX crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVAX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
NVAX broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 58 cases where NVAX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The 50-day moving average for NVAX moved above the 200-day moving average on September 24, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +4.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where NVAX advanced for three days, in 193 of 242 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 91 of 116 cases where NVAX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-8.718) is normal, around the industry mean (3.162). P/E Ratio (-6.588) is within average values for comparable stocks, (-1.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (131.622) among similar stocks. P/S Ratio (3.759) is also within normal values, averaging (439.647).
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. NVAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a company which engages in development of novel recombinant vaccines
Industry Biotechnology
Advertisement